United States · FDA National Drug Code directory
PURIXAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62484-0020_b8e1aeb8-2f0a-41b0-84d7-2c33a407926b
- Product NDC
- 62484-0020
- Form
- SUSPENSION
- Composition / generic term
- Purixan
- Labeler
- Nova Laboratories, Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140428
- Source listing expiry
- 20271231
Source-listed ingredients
- MERCAPTOPURINE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1) · 62484-0020-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →